ArticleJournal of functional biomaterials2025
Phase-Pure Hydroxyapatite/β-Tricalcium Phosphate Scaffolds from Ultra-Pure Precursors: Composition Governs Porosity, Strength, and SBF Kinetics.
Article in Journal of functional biomaterials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Morphological and Rheological Analysis of an Injectable Calcium Hydroxylapatite Dermal Filler with Lattice-Pore Surface Architecture.Journal of functional biomaterials · 2026Article
- Upcycling Tunisian dental plaster waste into β-tricalcium phosphate: process optimizationRSC advances · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Biphasic calcium phosphate (BCP)scaffolds comprising hydroxyapatite (HA) and β-tricalcium phosphate (β-TCP) were produced from ultra-pure precursors and processed under an α-TCP-avoiding schedule (1100 °C, 2 h). Quantitative X-ray diffraction (Rietveld/Profex) detected no α-TCP above the ~1 wt% limit of detection and quantified post-sintering phase fractions (wt% HA/β-TCP): 99.26/0.74, 68.51/31.49, and 27.57/72.43. Across compositions, SEM/ImageJ yielded similar mean macropore sizes (≈71-80 µm), while open porosity increased with the HA fraction (27.5 ± 1.8%, 39.1 ± 2.0%, 57.1 ± 2.4%). Compressive strength decreased accordingly (1.07 ± 0.25, 0.24 ± 0.01, 0.05 ± 0.02 MPa), consistent with non-load-bearing use. In ISO-compliant simulated body fluid (28 d), medium pH remained stable (7.33-7.43); mass loss and early Ca
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.